Fresh findings surround retatrutide, a dual agonist for GLP-1 and the second receptor, demonstrate promising capability in treating excess body fat and connected metabolic-related ailments. Preliminary testing show https://retatrutideresearchlab.co.uk/product/ozempic-025-mg/